Delivery Order SPE2DB22D2103-SPE2DB25FR9CF

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $67K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of Otezla 30 mg tablets to DLA Troop Support Medical facilities in support of military treatment programs and facilities. The award has a ceiling value of $30,322.24 and a period of performance through April 4, 2024. This delivery order is part of a larger indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Otezla (apremilast) 30 mg tablets. The contract has a ceiling value of $44,862.00 and a period of performance extending to May 12, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $96,872.70 and a period of performance through August 27, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,132.83, is for the supply of Otezla 30 mg tablets. It is a firm fixed-price contract with a period of performance through March 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat certain autoimmune conditions. The contract has a firm fixed price and a ceiling value of $10,371.86, with a period of performance through April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $109,360.93 and a period of performance through April 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The total ceiling value of the contract is $25,170.57, and it is a Firm Fixed Price contract type. The award was made on September 19, 2024, with a period of performance through September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 mg tablets, a prescription medication. The award has a ceiling value of $11,404.34 and a period of performance through April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 60 tablets of the medication Otezla 30 mg. The contract has a ceiling value of $5,721.60 and a completion date of June 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTEZLA 30 mg tablets. The contract has a ceiling value of $40,332.44 and an ultimate completion date of September 30, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR9CF
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $66,507.90 and a period of performance through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. This award demonstrates AmerisourceBergen's role as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/17/25, 6:29 PM